Search research articles
Contact Us
Filters
Showing results (291-300 of 361) with videos related to
Page
of 37
Sort By:
JAMA Network Open
|
August 20, 2025
Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials
Soumyajit Roy, Zeynep Irem Ozay, Avirup Guha, et al.
JNCI Cancer Spectrum
|
May 6, 2020
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel
Susan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
European Urology
|
March 15, 2024
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective Study
Manuel Weber, Wolfgang P Fendler, Aravind S Ravi Kumar, et al.
Journal for Immunotherapy of Cancer
|
May 13, 2021
<i>TERT</i> promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
Ivan de Kouchkovsky, Li Zhang, Errol J Philip, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 10, 2009
Bladder cancer. Clinical practice guidelines in oncology
James E Montie, Robert R Bahnson, Samuel M Cohen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 23, 2006
Bladder cancer. Clinical guidelines in oncology
James E Montie, Neil A Abrahams, Robert R Bahnson, et al.
The Pharmacogenomics Journal
|
March 4, 2024
Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance)
Jai N Patel, Chen Jiang, Kouros Owzar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2018
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel
Susan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2021
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
Jonathan E Rosenberg, Karla A Ballman, Susan Halabi, et al.
JAMA Oncology
|
September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer
Rahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
Page
of 37
Search research articles
Search
Showing results (291-300 of 361) with videos related to
Sort By:
Page
of 37
JAMA Network Open
|
August 20, 2025
Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials
Soumyajit Roy, Zeynep Irem Ozay, Avirup Guha, et al.
JNCI Cancer Spectrum
|
May 6, 2020
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel
Susan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
European Urology
|
March 15, 2024
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective Study
Manuel Weber, Wolfgang P Fendler, Aravind S Ravi Kumar, et al.
Journal for Immunotherapy of Cancer
|
May 13, 2021
<i>TERT</i> promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
Ivan de Kouchkovsky, Li Zhang, Errol J Philip, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 10, 2009
Bladder cancer. Clinical practice guidelines in oncology
James E Montie, Robert R Bahnson, Samuel M Cohen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 23, 2006
Bladder cancer. Clinical guidelines in oncology
James E Montie, Neil A Abrahams, Robert R Bahnson, et al.
The Pharmacogenomics Journal
|
March 4, 2024
Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance)
Jai N Patel, Chen Jiang, Kouros Owzar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2018
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel
Susan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2021
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
Jonathan E Rosenberg, Karla A Ballman, Susan Halabi, et al.
JAMA Oncology
|
September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer
Rahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
Page
of 37